HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · Real-Time Price · USD
15.04
-0.21 (-1.38%)
At close: Mar 31, 2025, 4:00 PM
15.08
+0.04 (0.30%)
After-hours: Mar 31, 2025, 6:47 PM EDT
HUTCHMED (China) Market Cap
HUTCHMED (China) has a market cap or net worth of $2.56 billion as of March 31, 2025. Its market cap has decreased by -20.77% in one year.
Market Cap
2.56B
Enterprise Value
1.80B
1-Year Change
-20.77%
Ranking
Category
Stock Price
$15.04
Market Cap Chart
Since March 17, 2016, HUTCHMED (China)'s market cap has increased from $1.60B to $2.56B, an increase of 60.45%. That is a compound annual growth rate of 5.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 2.66B | 5.86% |
| Dec 31, 2024 | 2.51B | -19.95% |
| Dec 29, 2023 | 3.14B | 22.75% |
| Dec 30, 2022 | 2.56B | -50.05% |
| Dec 31, 2021 | 5.12B | 19.79% |
| Dec 31, 2020 | 4.27B | 27.79% |
| Dec 31, 2019 | 3.34B | 8.92% |
| Dec 31, 2018 | 3.07B | -35.89% |
| Dec 29, 2017 | 4.79B | 195.91% |
| Dec 30, 2016 | 1.62B | 1.27% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 727.96B |
| UnitedHealth Group | 478.18B |
| Johnson & Johnson | 398.95B |
| AbbVie | 366.14B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 228.74B |
| Merck & Co. | 225.02B |